APOA1 anticorps (N-Term)

N° du produit ABIN1888023

Cet anticorps anti-APOA1 est un anticorps Lapin Polyclonal détectant APOA1 dans WB, ELISA et IF. Adapté pour Humain, Souris et Rat.

Aperçu rapide pour APOA1 anticorps (N-Term) (ABIN1888023)

Antigène: APOA1 (Apolipoprotein A-I (APOA1))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp APOA1 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunofluorescence (IF)

Détail du produit anti-APOA1 anticorps

Épitope: N-Term

Purification: Affinity chromatography purified via peptide column

Immunogène: 17 amino acid peptide from near the amino terminus of human ApoA1.

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.

Conseil sur la manipulation: Avoid freezing and thawing repeatly.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C for short term use.Store at -20 °C for long term preservation.

Détails sur APOA1

Antigène: APOA1 (Apolipoprotein A-I (APOA1))

Autre désignation: ApoA1

Sujet: Apolipoprotein A1 (ApoA1) is the major protein component of high density lipoprotein (HDL) in plasma.ApoA1 is synthesized in the liver and small intestine and promotes cholesterol efflux from tissues to the liver for excretion.It is a cofactor for lecithin cholesterolacyltransferase (LCAT), the enzyme responsible for the formation of most plasma cholesteryl esters.Defects in ApoA1 are associated with HDL deficiency, Tangier disease, and systemic non-neuropathic amyloidosis.
Synonyms: ApoA1, Apolipoprotein A1, ApoAI

UniProt: P02647

Pathways: Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism